These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6332414)

  • 1. [Determination of the von Willebrand factor].
    Turek P; Sikorová J; Vorlová Z
    Vnitr Lek; 1984 Jun; 30(6):550-6. PubMed ID: 6332414
    [No Abstract]   [Full Text] [Related]  

  • 2. [Simple rapid test for assaying ristocetin cofactor].
    Aznar JA; Borrego D; Martín G; Jorquera J; Jiménez C; García I; Marty ML
    Sangre (Barc); 1982; 27(5):959-66. PubMed ID: 6984787
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].
    Caduff T; Straub PW
    Schweiz Med Wochenschr; 1979 Mar; 109(11):399-402. PubMed ID: 34214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: A method for assaying von Willebrand factor (ristocetin cofactor).
    Macfarlane DE; Stibbe J; Kirby EP; Zucker MB; Grant RA; McPherson J
    Thromb Diath Haemorrh; 1975 Sep; 34(1):306-8. PubMed ID: 1081281
    [No Abstract]   [Full Text] [Related]  

  • 6. [Von Willebrand factor. Its role in hemostasis and the method of its determination].
    Baluda VP; Sushkevich GN
    Lab Delo; 1976; (8):451-5. PubMed ID: 66393
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quantitative determination of Willebrand factor activity in Willebrand's disease].
    Buchvarova V; Samama M; Lecrubier C
    Vutr Boles; 1976; 15(3):92-4. PubMed ID: 1086035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet.
    Hashimoto S; Suzuki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):851-63. PubMed ID: 317771
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Purification of ristocetin Willebrand factor (RWF).
    Olson JD; Fass DN; Brockway WJ; Bowie EJ; Mann KG
    Thromb Diath Haemorrh; 1975 Nov; 34(2):606. PubMed ID: 1081753
    [No Abstract]   [Full Text] [Related]  

  • 10. A simplified assay for von Willebrand factor.
    Rivard GE; Daviault MB
    Thromb Res; 1978 Apr; 12(4):677-80. PubMed ID: 307285
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of ristocetin and von Willebrand factor.
    Jenkins CS; Meyer D; Larrieu MJ
    Thromb Haemost; 1976 Jun; 35(3):752-3. PubMed ID: 1086517
    [No Abstract]   [Full Text] [Related]  

  • 12. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study on two methods of quantitative assay for von Willebrand factor using a washed-platelet-system and a fixed-washed-platelet-system (author's transl)].
    Kajikawa M; Taketomi Y; Ihara A; Nakagawa J; Fujimura K
    Rinsho Ketsueki; 1976 Aug; 17(8):868-75. PubMed ID: 1088552
    [No Abstract]   [Full Text] [Related]  

  • 14. Assay of ristocetin cofactor: experience with a platelet counting technique.
    Bird AR; Sacks R; Smith A
    Med Lab Sci; 1984 Jan; 41(1):38-45. PubMed ID: 6609295
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet aggregation and von Willebrand's factor in 32 insulin-dependent diabetics. Value of the measurement of filtration pressure in the presence of ADP].
    Prost-Dvojakovic RJ; Lecrubier C; Lanoe R; Batchvarova V; Samama M
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():239-47. PubMed ID: 1087675
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased platelet function and von Willebrand factor in vibration syndrome.
    Ikehata K; Kawauchi S; Kohno F; Nishiyama M; Ide N
    Tokushima J Exp Med; 1980 Jun; 27(1-2):23-8. PubMed ID: 6968462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Von Willebrand factor and the antiaggregation activity of the vascular wall in diabetics].
    Sokolov EI; Baluda MV; Baluda VP; Balabolkin MI; Novikova IV; Deianov II; Timofeeva AV
    Ter Arkh; 1991; 63(4):104-5. PubMed ID: 1648796
    [No Abstract]   [Full Text] [Related]  

  • 18. Ristocetin-Willebrand factor activity in dog plasma.
    Johnstone IB; Lotz F
    Can J Physiol Pharmacol; 1980 Sep; 58(9):1128-34. PubMed ID: 6970064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood platelet disorders. I. Genetically determined syndrome].
    Michalski R; Pniejnia-Olszyński W
    Acta Haematol Pol; 1977; 8(1):49-55. PubMed ID: 322436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.